Isofol Medical AB (publ) - ESG Rating & Company Profile powered by AI
The report of Isofol Medical AB (publ) uses data points from across the web as well as from public disclosures by Isofol Medical AB (publ). Other corporations in the scoring peer group for Isofol Medical AB (publ) are displayed. Detailed Sustainability analysis of Isofol Medical AB (publ) are reached by signing up for free.
Isofol Medical AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 2.7, social score of 8.0 and governance score of 2.0.
4.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 951 | Purple Biotech Ltd | 4.3 | High |
| 951 | Vectura Group Services Ltd | 4.3 | High |
| 969 | Isofol Medical AB (publ) | 4.2 | High |
| 969 | Botanix Pharmaceuticals Ltd | 4.2 | High |
| 969 | Arvinas Inc | 4.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Isofol Medical AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose current and historical energy intensity?
Sign up for free to unlockDoes Isofol Medical AB (publ) report the average age of the workforce?
Sign up for free to unlockDoes Isofol Medical AB (publ) reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose its ethnicity pay gap?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose cybersecurity risks?
Sign up for free to unlockDoes Isofol Medical AB (publ) offer flexible work?
Sign up for free to unlockDoes Isofol Medical AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Isofol Medical AB (publ) conduct supply chain audits?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Isofol Medical AB (publ) conduct 360 degree staff reviews?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose the individual responsible for D&I?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose water use targets?
Sign up for free to unlockDoes Isofol Medical AB (publ) have careers partnerships with academic institutions?
Sign up for free to unlockDid Isofol Medical AB (publ) have a product recall in the last two years?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose incidents of discrimination?
Sign up for free to unlockDoes Isofol Medical AB (publ) allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Isofol Medical AB (publ) issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose parental leave metrics?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose the pay ratio of women to men?
Sign up for free to unlockDoes Isofol Medical AB (publ) support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Isofol Medical AB (publ) reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Isofol Medical AB (publ) involved in embryonic stem cell research?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose its waste policy?
Sign up for free to unlockDoes Isofol Medical AB (publ) report according to TCFD requirements?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose energy use targets?
Sign up for free to unlockDoes Isofol Medical AB (publ) disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Isofol Medical AB (publ) have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Isofol Medical AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, Solasia Pharma KK, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.